Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

PHASE2RecruitingINTERVENTIONAL

Enrollment

266

Participants

Timeline

Start Date

August 7, 2024

Primary Completion Date

July 1, 2027

Study Completion Date

January 1, 2028

Conditions

Liver Neoplasms

Interventions

DRUG

Sulfur Hexafluoride Lipid Microspheres

Given IV

PROCEDURE

Contrast-Enhanced Ultrasound

Undergo CEUS

PROCEDURE

Transarterial Chemoembolization

Undergo TACE

OTHER

Medical Chart Review

Ancillary studies

Trial Locations (1)

RECRUITING

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

john eisenbrey

OTHER